Overview

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

Status:
Terminated
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study KOS-862 in men with metastatic prostate cancer who have failed a docetaxel-containing regimen.
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Desoxyepothilone B